AIM
STJ

Acrospire Investment Management’s St Jude Medical STJ Stock Holding History

Acrospire Investment Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-400
Closed -$31K – 2320
2016
Q2 		$31K Sell
400
-1,200
-75% -$85.6K 0.02% 1378
2016
Q1 		$88K Buy
+1,600
New +$87.2K 0.06% 415

Other funds holding STJ

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Acrospire Investment Management's STJ Position: Q3 2016 in Review

Acrospire Investment Management sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 400 shares — an estimated $31K sold.

Acrospire Investment Management first reported a position in STJ in Q1 2016 and held it in 2 quarters. The position peaked at $88K in Q1 2016. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

  • Acrospire Investment Management reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
  • Acrospire Investment Management sold 400 St Jude Medical shares in Q3 2016, an estimated $31K.
  • Acrospire Investment Management first reported a position in St Jude Medical in Q1 2016 and held it in 2 quarters.
  • Acrospire Investment Management's St Jude Medical position peaked at $88K in Q1 2016.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Acrospire Investment Management's 13F filing for Q3 2016, filed 10 Nov 2016.